American Oncology Network | Strategic Alliance Partnership

News from our Strategic Alliance Partners.

An analysis presented during the 64th American Society of Hematology Annual Meeting and Exposition showed that patients with multiple myeloma were able to experience improved responses to the proteasome inhibitor ixazomib after switching from bortezomib.

Constructive advice on improving the Enhancing Oncology Model (EOM) from our expert panel.

The Enhancing Oncology Model allows pooling of groups of practices for quality measurement, which was not permitted under the OCM.

Asking for help to prepare for the Enhancing Oncology Model (EOM) and 2-sided risk is advised, say panelists experienced with the Oncology Care Model (OCM).

As terms for Monthly Enhanced Oncology Services (MEOS) payments are set to change under the EOM, panelists worry that the barriers to entry to value-based care will be too high for practices that did not participate in the OCM.

Panelists see the 5-year period of the Enhancing Oncology Model as reasonable; they would like see some progress toward permanent value-based payment structures.

Addressing cancer patients' lack of housing or food insecurity affects care outcomes, but how can the Center for Medicare and Medicaid Innovation build this into a reward structure?

Cutting the amount of Monthly Enhanced Oncology Services payments and limiting qualifying tumor types will curtail revenue to practices. But after the financial results in the Oncology Care Model, that's by design.

Unlike the Oncology Care Model, the Enhancing Oncology Model will focus on 7 common cancer types, which experts say offers advantages and disadvantages for practices.

In a sign that value-based care is here to stay, some practices that did not participate in the Oncology Care Model (OCM) have applied for the Enhancing Oncology Model (EOM).

The Center for Medicare and Medicaid Innovation (CMMI) was a strong collaborator during the Oncology Care Mode (OCM), but the timing of the Enhancing Oncology Model came as a surprise.

Experts from US Oncology, Tennessee Oncology, AON, and COA dig into the details of implementing the Enhancing Oncology Model, set to take effect July 1, 2023.

American Oncology Network (AON) announced that they have entered into a definitive business combination agreement and will become a public company.

American Oncology Network (AON) commented against CMS' proposed CY 2023 Outpatient Prospective Payment System stating it will have grave effects on the sustainability of community oncology practices.

The American Oncology Network was ranked number 107 on the 2022 Inc. 5000 Annual List.

Three abstracts coauthored by American Oncology Network physicians were presented at the American Society of Clinical Oncology Annual Meeting.

American Oncology Network (AON) announced the appointment of Stephen "Fred" Divers, MD, a medical oncologist with Genesis Cancer and Blood Institute, as its new chief medical officer.

The CEO of the American Oncology Network cited the growing need for financial assistance in announcing the partnership.

The American Oncology Network is committed to reducing health inequities and close the gap in cancer care.

The American Oncology Network, LLC, has added 5 medical oncologists to its Executive Committee.

American Oncology Network, LLC (AON) is pleased to announce that The Center for Cancer and Blood Disorders (CCBD), a leading community oncology and hematology practice serving Bethesda and Germantown, Maryland, has joined AON.

American Oncology Network, LLC (AON) is pleased to announce that Cancer and Blood Specialists of NOVA, a leading community oncology and hematology practice serving Northern Virginia, has joined AON.

American Oncology Network, LLC (AON) is pleased to announce that The Center for Cancer and Blood Disorders (CCBD), a leading community oncology and hematology practice serving Bethesda and Germantown, Maryland, has joined AON.

Schonherz will be responsible for day-to-day operations.

American Oncology Network, LLC (AON) is pleased to announce that Vista Oncology, a leading community oncology/hematology practice serving the Olympia, Washington community, has joined AON, effective December 1, 2019.

Since its inception in 2017, the American Oncology Network, LLC (AON) has participated in the Oncology Care Model (OCM), a national innovative payment program of the Center for Medicare & Medicaid Innovation (CMMI).

American Oncology Network, LLC (AON) is pleased to announce that Heartland Oncology & Hematology, a leading community oncology/hematology practice in Council Bluffs, Iowa, will be joining AON, effective November 1, 2019.